Psoriasis Treatment History Events

1798 Psoriasis is First Clinically Described by Robert Willan
Plenck doesn’t compared the Psoriasis from other skin diseases discovered until Robert Willan (1757-1812), an English dermatologist together with Thomas Bateman recognized this disease as...
1841 Viennese Dermatologist, Ferdinand von Hebra, Titles Skin Condition Psoriasis
While it may have been visually, and later semantically, confused with leprosy, it was not until 1841 that the condition was finally given the name psoriasis by the Viennese dermatologist...
1903 Niels Finsen Uses Phototherapy to Treat Skin Diseases
Phototherapy has a very long, albeit mostly anecdotal history. Real interest in the use of ultraviolet irradiation in the treatment of various diseases started in the 19th century and rea...
1953 Dec 7 FDA Approves Dava's Methotrexate
Methotrexate interferes with the growth of certain cells of the body, especially cells that reproduce quickly, such as cancer cells, bone marrow cells, and skin cells. Methotrexate is ...
1971 Jun 30 FDA Approves Medicis's Lidex
Treating inflammation and itching due to certain skin conditions. It may also be used for other conditions as determined by your doctor. Lidex Cream is a topical adrenocortical steroid...
1978 Mar 1 FDA Approves Pharmacia and UpJohn's Psorcon
Psorcon is prescribed for the relief of the inflammation and itching of skin disorders that respond to the application of steroids (hormones produced by the body that have potent anti-inf...
1982 Dec 14 FDA Approves GlaxoSmithKlein's Aclovate
This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Alclometasone reduces the swelling, itching, and redness that can occur in these...
1985 Dec 27 FDA Approves Galderma's Clobex Lotion to Treat Psoriasis
Treating inflammation and itching due to certain skin conditions. It is also used to treat moderate to severe psoriasis. It may also be used for other conditions as determined by your doc...
1987 Apr 30 FDA Approves Schering-Plough's Elocon
Elocon is a topical (for the skin) steroid. It reduces the actions of chemicals in the body that cause inflammation, redness, and swelling. Elocon is used to treat the inflammation and...
1990 Dec 17 FDA Approves Ranbaxy's Ultravate
Treating inflammation and itching caused by certain skin conditions. It may also be used for other conditions as determined by your doctor. Ultravate Cream is a topical corticosteroid....
1993 Dec 29 FDA Approves LEO's Dovonex to Treat Psoriasis
Dovonex (calcipotriene) is a synthetic topical form of vitamin D. It is involved in the growth and development of skin cells. Dovonex is used to treat plaque psoriasis (psoriasis with ...
1995 Jul 14 FDA Approves Novartis's Neoral
Preventing the rejection of organ transplants (kidney, liver, and heart). Neoral is also used to treat psoriasis and rheumatoid arthritis in certain patients. It may also be used for othe...
1996 Oct 28 FDA Approves Stiefel's Soriatane
Treating severe psoriasis. Soriatane is a kit that contains a vitamin A derivative (retinoid) and moisturizing foam. Exactly how the retinoid works is not known. The moisturizing foam ...
1997 Jun 13 FDA Approves Allergan's Tazorac
Tazarotene is a vitamin A derivative, topical retinoid used to slow skin cell growth. It is normal for psoriasis plaques to become very red before clearing when using tazarotene. The redn...
1998 Aug 24 FDA Approves Centocor's Remicade
Remicade reduces the effects of a substance in the body that can cause inflammation. Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohn's di...
1998 Nov 2 FDA Approves Immunex's Enbrel
Enbrel works by decreasing a certain protein produced by the immune system. The immune system helps the body fight infections. In people with autoimmune disorders, the immune system mista...
2001 Mar 21 FDA Approves BARR's Trexall
Treating certain types of cancer, severe psoriasis, or rheumatoid arthritis in certain patients. It may be used alone or with other medicines. It may also be used for other conditions as ...
2002 Dec 31 FDA Approves Abbott's Humira
Humira reduces the effects of a substance (tumor necrosis factor alpha) in the body that can cause inflammation. Humira is used to treat rheumatoid arthritis, juvenile idiopathic arthr...
2003 Jan 30 FDA Approves Biogen's Amevive
In March 2003 the US Food and Drug Administration (FDA) approved alefacept (Amevive) for treatment of moderate to severe plaque psoriasis. Amevive, manufactured by Biogen, is an immune sy...
2006 Jan 9 FDA Approves LEO's Taclonex
Taclonex contains a combination of betamethasone and calcipotriene. Betamethasone is a topical corticosteroid. It reduces swelling, relieves itching, and constricts blood vessels. Calcipo...
2006 Apr 3 Biogen Sells Rights to Amevive to Astellas
Astellas Pharma Canada, Inc. today announced that U.S. affiliate company Astellas US LLC has concluded an agreement to purchase the worldwide rights to AMEVIVE(R) (alefacept) as of March ...
2009 Sep 25 FDA Approves Centocor Ortho's Stelara
STELARA™ is a prescription medicine approved to treat adults 18 years and older with moderate or severe psoriasis that involves large areas or many areas of their body, who may benefit fr...